Drugs / RO7823653
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07425522 | Apr 2026 → Nov 2028 expected | diabetic macular edema | Genentech, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7823653 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07425522 ↗ |
| Route | Intravitreal | “administered by intravitreal (IVT) injection” NCT07425522 ↗ |